Journal of Nutrition EB Program 2010 Abstracts

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beard, J.
Right arrow Articles by Jones, B. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beard, J.
Right arrow Articles by Jones, B. C.

© 2003 The American Society for Nutritional Sciences J. Nutr. 133:1174-1179, April 2003

Neonatal Iron Deficiency Results in Irreversible Changes in Dopamine Function in Rats

John Beard*,1, Keith M. Erikson{dagger} and Byron C. Jones**

* Graduate Program in Nutrition, {dagger} Physiology and Pharmacology, Wake Forest University School of Medicine, Winston-Salem, NC 27157 and ** Biobehavioral Health and Pharmacology, The Pennsylvania State University, University Park, PA 16802

1To whom correspondence should be addressed. E-mail: its{at}psu.edu.


    ABSTRACT
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 LITERATURE CITED
 
Iron deficiency in human infants and in young animal models produces changes in neural functioning that may be related to monoamine metabolism. This study employed both behavioral and biochemical approaches in a design using cross-fostering to examine alterations in dopamine (DA) function when iron deficiency occurs during the neonatal period. We measured brain Fe, dopamine transporters (DAT) and dopamine receptor density in rats made iron deficient, or not, from postnatal day (PND) 4 to PND 14 or 21. Some pups were then weaned to an iron-deficient diet and others to the control diet to examine the reversibility of these effects. Behaviors related to dopamine function were measured. Dopamine D2 receptor (D2R), D1R and iron concentrations were ~70, 80 and 30% of control values, respectively, in the nucleus accumbens and striatum in iron-deficient rats at PND 14. The DAT density was also reduced to 50% of control density in the nucleus accumbens but was unchanged in the striatum. By PND 21, there was also a significant 50% lowering of DAT, D1R and D2R densities in the prefrontal cortex (PFC). Iron repletion at PND 21–49 normalized D1R, D2R, and DAT levels in the nucleus accumbens, PFC and ventral midbrain but not in the striatum. In summary, neonatal iron deficiency is associated with changes in DA biology that vary with duration of iron deficiency, and are not completely normalized despite replenishment of iron status. Changes in DA-related behaviors that were persistent after postweaning iron repletion suggest the existence of a critical neonatal developmental period that is expressed by alterations in DA functioning.


KEY WORDS: • dopamine • dopamine receptors • dopamine transporter • iron deficiency • prefrontal cortex • rats

Iron is involved in numerous neurological functions. The effects of iron deficiency (ID) on behavior have been widely investigated in humans and in experimental animals. Studies in adults and in children demonstrate that iron deficiency is associated with apathy, irritability, lethargy, lack of concentration, increased anxiety, hypoactivity, and decreased cognition and attention. Despite major methodological differences among early (1 ,2 ) and later studies [reviewed in (37 )], remarkably similar results are reported. The biological basis of ID-related cognitive and behavioral alterations is unclear; however, a conceptual model of contributing factors must include environmental as well as biological factors (4 ,8 ). The biological variables are related to decreased brain iron, and likely include hypomyelination, impaired dopaminergic function and delayed neuromaturation (810 ). Auditory evoked potential studies in 6-mo-old iron-deficient infants showed increased central conduction times consistent with either hypomyelination or altered monoamine metabolism (10 ). One way of determining causality is to utilize animal models that focus on the relationship of neurotransmitters in limbic structures to behaviors that appear to be adversely affected by iron deficiency in human infants (4 ).

The effects of iron on neurological functioning in rodents are related to the brain levels of iron, not to anemia per se (11 ,12 ). Induction of iron deficiency in postweaning rats results in decreased densities of dopamine (DA) D2 receptors (D2R), increased extracellular DA, and blunted DA reuptake in vivo, (1214 ). Iron-deficient rats are less active than control rats when placed in a novel environment; they explore less and are more "fearful" than control rats (15 ,16 ). These behaviors are dependent in part on dopaminergic function in nigrostriatal and mesocorticolimbic pathways and are the basis for our somewhat selective examination of certain brain regions. The previously cited studies demonstrated a reversible relationship of regional brain iron to DA and to behaviors, but they did not identify a "critical period" of development. In human infants suffering from iron deficiency, that critical period appears to be during the first 12–18 mo of life.

Rodent studies of neonatal iron deficiency demonstrated developmentally dependent rates of depletion of brain iron with dietary deficiency and a failure to correct abnormal behaviors even though the regional brain iron contents were restored to normal levels within 2 wk of feeding a high iron diet (17 ). In the current studies, we investigated the relationship of neonatal iron deficiency with dopamine metabolism; furthermore, we sought to determine whether the above-mentioned effects were normalized after dietary iron intervention.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 LITERATURE CITED
 
Design.

An out-fostering regimen was implemented to produce iron deficiency postnatally but before weaning in pups, as described by Pinero et al. (17 ). On postnatal day (PND) 4 of life, we placed iron-sufficient pups with lactating dams that had been fed an iron-deficient diet from midgestation to term. We then conducted an intervention study with experimental groups in which rats were made iron deficient between PND 4 and 14, between PND 4 and 21 or between PND 21 and 49. To examine reversibility of effect, we also included rats made iron deficient between days 4 and 21 and subsequently fed an iron-sufficient diet until d 49 of age. Each experimental group was compared with a control cohort group fed an iron-sufficient diet. All experimental (and control) rats were killed on the day of the regimen as specified.

Animals and dietary treatment.

Male and female Sprague-Dawley rats (180–200 and 140–160 g, respectively) were purchased from Harlan Sprague Dawley (Indianapolis, IN). The female rats were fed a control diet (35 Fe mg/kg diet) and the males were fed a standard nonpurified diet (Laboratory Rodent Diet, PMI Nutrition International, Brentwood, MO). At age 49 d, the females were mated with a male for 5 d (two females and one male), after which the females were removed and placed in individual home cages. Pregnancy was defined by the appearance of vaginal plugs. The dams were weighed every other day to confirm the pregnancies.

After pregnancy was determined, the dams were fed an iron-deficient diet (3 mg Fe/kg diet) at midgestation or continued to consume the control diet. The first morning that the pups appeared in the cages was considered PND 1. At PND 4, rats from the control dams were randomly assigned to iron-deficient dams or to dams fed the control (CN) diet. To control for the effects of outfostering, per se, a number of pups born to control dams were fostered with another control dam until weaning. Some of these pups were then weaned to a low iron diet (3 mg Fe/kg) and others to a control diet (35 mg Fe/kg). No pups utilized in these studies experienced iron deficiency in utero. There were roughly equal numbers of male and female pups in each litter, but only data from males are included. Although we did not measure milk iron and pup milk consumption, previous studies (17 ,18 ) demonstrated that this protocol decreases milk iron concentration and that pups consume normal amounts of milk per gram of body weight.

Dietary treatment.

The diets were prepared as described elsewhere, (18 ) and met all nutrient requirements with the exception of iron in the low iron diet. All diets were formulated according to the guidelines of the AIN, with cornstarch as the sole source of carbohydrate (19 ). By analysis, the diet iron concentrations were 36.7 ± 0.7 mg Fe/kg for the control diet and 3.15 ± 0.5 mg Fe/kg for the iron-deficient diet. All rats had free access to food and water 24 h/d, and lights were turned off between 1800 and 0600 h. The room temperature was maintained at 25 ± 1°C. The Pennsylvania State University Animal Care and Use Committee approved all animal procedures.

The iron status of the dams was closely monitored by measuring hemoglobin (Hb) and hematocrit (Hct) before mating, at midpregnancy, at delivery, at midlactation and at weaning as previously described (17 ).

Hematological and liver nonheme iron.

Hemoglobin was measured colorimetrically by the cyanomethemoglobin method and Hct was determined by centrifugation (9,000 g, for 5 min) of blood collected into heparinized microcapillary tubes. Liver nonheme iron was determined using the standard colorimetric technique described by Cook (20 ) with ferrozine as the color reagent.

Iron repletion.

Separate groups of ID rats were weaned to a control diet for 4 wk (IDCN) starting at PND 21. Corresponding age-matched control rats (CNCN) that were iron sufficient at all times were also used. After 4 wk of dietary iron repletion, behavioral measures were obtained before killing and brain iron and dopamine variables were measured.

Locomotor behavior tests.

Rats at PND 21 and after 4 wk of iron repletion were subjected to behavior tests (ambulation and stereotypy) via an automated activity monitor according to methods previously described (21 ,22 ).

Densities of dopamine receptors and the dopamine transporter (DAT).

Brains from freshly killed rats were dissected, membrane fractions prepared and radioligand binding assays performed as described previously (22 ,23 ). The ligands used were 3H-SCH23390, 125I-epidepride and 3H-GBR 12935 for D1R, D2R and the DAT, respectively. All assays were conducted in random order. Maximum binding values were normalized to protein concentrations as determined by the micro-Lowry assay (P5656 Sigma Chemical, Natick, MA).

Iron analysis.

Total iron content of brain region homogenates was determined using atomic absorption spectrophotometry (24 ).

Statistical analysis.

Dopamine receptor and transport measures were analyzed by ANOVA. The between-subject factor was diet and the within-subject factor was brain region. The behavioral variables were subjected to ANOVA for a between-subjects variables analysis (diet). Student’s t test for samples with unequal variances was used to test effects of dietary treatment on hematological measures and liver nonheme iron. Tukey’s Honestly Significant Difference post-hoc test was used to evaluate differences between means with {alpha} set at P < 0.05. Estimated {omega}2 were calculated for significant main effects and interaction to show the proportion of variance in the measure attributable to the factor or to interaction (25 ).


    RESULTS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 LITERATURE CITED
 
Biological data.

The period of early neonatal ID refers to the dietary iron deficiency induced between PND 4 and 14. Complete neonatal iron deficiency refers to iron deficiency from PND 4 to 21. Hematologic indices demonstrated that rats cross-fostered to iron-deficient dams were iron deficient at PND 14 and 21 and had significantly lower body weights than controls (Table 1 ). There were age- and region-specific effects of iron deficiency on brain iron concentration. For example, at PND 14, iron-deficient rats had a slightly higher concentration of iron in the prefrontal cortex (PFC) than control rats, but 60–70% lower concentrations in striatum and nucleus accumbens [F (1,12) = 12.4, est. {omega}2 = 0.143]. Another week of dietary iron deficiency to PND 21 diminished the rapid accumulation of iron in the PFC and ventral midbrain compared with controls [F (1,12) = 18.6, est. {omega}2 = 0.347] but did not prevent the accumulation of iron in the striatum or nucleus accumbens.


View this table:
[in this window]
[in a new window]
 
TABLE 1 Hematological and brain iron concentrations in neonatal iron-deficient and control rats12

 
Binding of D1, D2 and DAT ligands.

Neonatal iron deficiency affected D1R density with a significantly lower D1R density in the striatum at PND 14 [F (1,12) = 12.3, {omega}2 = 0.221] (Table 2 ). D2R density was significantly lower in striatum at PND 14, [F (1,12) = 10.9, {omega}2 = 0.181], but was significantly higher in the PFC [F (1,12) = 8.4, {omega}2 = 0.162]. Iron deficiency decreased the density of the DAT in the accumbens and increased its density in the prefrontal cortex [F (1,12) = 12.2, {omega}2 = 0.192].


View this table:
[in this window]
[in a new window]
 
TABLE 2 Brain dopamine receptor and transporter densities in iron-deficient and control rats that experienced iron deficiency pre- and postweaning12

 
The densities of D1R and D2R in iron-deficient rats at PND 21 in striatum and in the nucleus accumbens were not different from in controls (Table 2 , Fig. 1a, b ). In nucleus accumbens and PFC, the DAT density in ID rats was significantly lower than in controls [nucleus accumbens and PFC F (1,22) = 9.6, {omega}2 = 0.266, F (1,22) = 7.3, {omega}2 = 0.190, respectively].



View larger version (45K):
[in this window]
[in a new window]
 
FIGURE 1 Percentage of control dopamine D1 receptor (D1R), D2R, dopamine transporter (DAT) densities, and iron concentration in striatum (A) and nucleus accumbens (B) of rats that were iron deficient from postnatal day (PND) 4 to 14 (14 d), from PND 4 to 21 (21 d), and rats fed an iron-deficient diet from PND 21 to 49 (49 d). Values are means ± SEM. See Table 1 for n. *Different from controls.

 
The densities of D1R, D2R and DAT were greater in controls than in ID rats in the striatum and accumbens in PND 49, rats [P < 0.01 in all cases]. In the PFC, D2R and DAT densities were greater in the ID rats at PND 49 [F (1,17) = 7.7, {omega}2 = 0.216].

Postweaning iron supplementation.

Iron repletion of neonatal iron-deficient rat pups commenced at weaning (IDCN) and resulted in significant improvements in hematologic measures, and D1R, D2R and DAT in brain regions (Table 3 ). The rats that were iron deficient from PND 4 to 21 and then made replete (IDCN) had a body weight of 191 ± 10 g, Hct of 0.39 ± 0.02 and liver iron of 2.54 ± 0.38 µmol/g. The rats that were iron sufficient throughout PND 4–49 (CNCN) had a body weight of 212 ± 13 g, Hct of 0.43 ± 0.02 and liver iron of 1.93 ± 0.36 µmol/g tissue. D1R density was significantly lower in striatum than control levels (CNCN) [F = 1,20; {omega}2 = 0.184] even though these rats were no longer anemic and body iron stores had been restored (Fig. 2 ). The D2R density measurements, however, presented the greatest surprise. They were 98 and 52% greater than in controls in the striatum and the nucleus accumbens, respectively [F = 1.90, {omega}2 = 0.284 and F = 1,28; {omega}2 = 0.194]. The DAT density remained lower in the striatum of iron-replete rats [F= 1,22; {omega}2 = 0.191] but other brain regions did not differ.


View this table:
[in this window]
[in a new window]
 
TABLE 3 Dopamine receptor (D1R, D2R) and transporter (DAT) densities in neonatal iron-deficient rats that were made iron replete postweaning (IDCN) and control rats (CNCN)1

 


View larger version (25K):
[in this window]
[in a new window]
 
FIGURE 2 Dopamine D1 receptor (D1R) densities (upper panel), D2R density (middle panel) and dopamine transporter (DAT) density (lower panel) in brains of iron-replete rats and control rats. N. Acc., nucleus accumbens; MPFC, medial prefrontal cortex; VMB, ventral midbrain.Values are means ± SEM, n = 8–16. *Different from controls, P < 0.01; **different from controls, P < 0.001.

 
Behavioral testing.

Iron-deficient rats at PND 21 showed significantly decreased levels of spontaneous movement and exploration of a novel environment than age-matched controls [F (1,10) = 7.7, {omega}2 = 0.245]. Iron repletion for 4 wk did not completely correct this behavioral effect because a significant difference in locomotion remained at PND 49 [F (1,10) = 11.2, {omega}2 = 0.493] (Fig. 3a ). Stereotypy (number of repeated movements) was also significantly lower in iron-deficient neonatal rats [F (1,8) = 4.6, {omega}2 = 0.177]; however, postweaning iron repletion reversed this effect (Fig. 3 b).



View larger version (24K):
[in this window]
[in a new window]
 
FIGURE 3 Total distance traveled by male rats of variable iron status in an open field chamber for a 20-min period (A) and number of repeated movements (B) at both 21 and 49 d of age. The groups of rats are controls (CNCN), neonatal iron-deficient rats made iron replete (IDCN) and postweaning iron-deficient rats (CNID). Values are means ± SEM. See Table 2 for n.*Different from other groups, P < 0.001; #different from CNCN, P < 0.001.

 

    DISCUSSION
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 LITERATURE CITED
 
The current experiments answered three important questions: 1) Does iron deficiency during the neonatal period change DA function? 2) Is there an effect of the duration of iron deficiency during the neonatal period on DA? 3) Is there a "complete normalization" of DA metabolism after iron repletion? We found that neonatal rat pups subjected to iron deficiency for only 10 or 17 d (PND 14 or 21) developed changes in DA function and behavior that were not corrected despite normalization of hematology and iron stores. This was suspected on the basis of our earlier studies that showed that brief periods of neonatal iron deficiency were sufficient to significantly alter brain iron concentrations (17 ). In that study, 2 wk of iron therapy did normalize the iron content of most regions of the brain, but some behaviors were resistant to complete normalization within that short time period (17 ,21 ). The current report provides some possible biologic explanations for those observations because we were able to demonstrate that DA metabolism is also not completely normalized after a longer 4-wk repletion period.

The acquisition of iron by different brain regions is quite different in the first neonatal period studied compared with the iron accumulation in the second neonatal period. The absolute concentrations of iron in the four regions examined show that striatum and accumbens accumulated much more iron in the first 10–14 d of the neonatal period than in the next 7 d, whereas the PFC and ventral midbrain displayed a "burst" of iron accumulation between PND 14 and 21. Thus, the effect of iron deficiency on brain iron concentrations is very dependent on the "timing" of the dietary deprivation. For instance, the striatum is sensitive to dietary iron depletion from PND 4 to 14, but an additional 7 d of dietary iron restriction did not reduce iron concentrations to levels below those at PND 14. In contrast, the nucleus accumbens is "insensitive" to dietary iron restriction during the first 10 d of iron deficiency but then "falls behind" very substantially in iron acquisition over the next week of growth when that region is very actively accumulating iron. The observation that high rates of iron accumulation occur in different brain regions at different ages of postnatal life was noted previously (17 ). The biological basis of this relative iron accumulation is not understood, but is likely mediated by changes in the cellular iron uptake proteins, divalent metal transporter protein and transferrin receptor, as well as changes in iron requirements with regional brain growth and development (21 ,26 ,27 ). Iron requirements for myelin production and oligodendrocyte metabolism would be expected to be high during the development of white matter regions, but other biological processes that require iron remain to be explored (10 ,17 ).

A key finding of this study is that the regional densities of DAT and D2R closely and positively follow the changes in iron concentration across the different ages studied. We previously observed a strong correlation between regional iron concentration and aspects of DA metabolism in postweaning iron-deficient rats (13 ,22 ,28 ). Multivariate regression analyses demonstrated that combinations of both iron concentrations and DA variables explained between 50 and 67% of the variation in exploratory behaviors and in latency in light-dark box behaviors in those studies. The argument that only DA variables and only certain brain regions are affected exclusively by iron deficiency is not likely to be valid (28 ); those studies documented only associations between particular dopaminergic pathways and behaviors known to be affected by dysfunction in those brain regions and pathways.

Dopaminergic neurons express transporters and receptors at different times in development and also experience a substantial amount of "pruning" of neural circuits with postnatal aging (2931 ). D2R density in some rat brain regions doubles from PND 7 to 14, increases by another 20% from PND 14 to 21 and by another 20–50% by PND 28 (31 ). The density of the DAT increases steadily throughout neonatal development to a maximal level by adulthood. In contrast, the density of D1R in primary dopaminergic regions is not age dependent during the neonatal period (28 ,30 ). Our demonstration that the densities of dopamine receptors rise and fall with iron status may indicate that iron has a role in DA neuron-specific apoptosis as well as specific effects on the expression of these proteins. This idea has been explored in cell culture in which acute iron chelation in both PC12 cells and neuroblastoma cells showed dose-response relationships between the expression of the DAT and amount of cellular iron deficiency (32 ).

The final key observation from the current study was that 4 wk of iron repletion resulted in incomplete normalization of DAT and receptor densities and some improvement, but not complete normalization, in all behaviors that were examined. Thus, our previous hypothesis that longer periods of iron repletion in rats would normalize behaviors is only partially supported (33 ,34 ). There is thus some support for the notion that even longer periods of iron therapy would result in complete normalization of the behaviors related to exploration of the environment. The biological explanation of the need for this longer period of iron therapy must hinge on events other than simply the iron content of a brain region because iron concentration is normalized in most brain regions within 14 d of dietary treatment (21 ,24 ). It is tempting to argue that the basis of the alterations in some behaviors that are resistant to normalization are related to irreversible changes in dopamine transporter and receptor levels in certain brain regions. We, and others, have already been established that iron-deficient rats have altered motor activity, exploratory behavior and stereotypy (1416 ,21 ). They also show more anxiety in both open field and light box-dark box behavior paradigms. Regression analysis showed these behaviors to be highly related to dopaminergic function in the nigrostriatal and mesocorticolimbic pathways (11 ,35 ) as well as to iron concentrations in ventral midbrain and striatum (34 ). As noted elsewhere, a number of other possible biological explanations remain viable at this time and are being explored (35 ).

In conclusion, these studies of neonatal iron deficiency and postweaning iron repletion provide important new evidence regarding the relationship of bran iron deficiency to behavior in several ways: 1) dopaminergic tracts are affected by iron deficiency during the neonatal period; 2) the early neonatal period has a different "susceptibility" than the second half of the neonatal period; 3) iron therapy for 4 wk normalizes DA transporter and receptor densities in the dopaminergic tracts, with the exception of D1R and DAT densities in striatum; and 4), behaviors known to be dependent on functioning of the striatal dopaminergic neurons remain changed despite iron therapy. Whether human infants with iron deficiency anemia also demonstrate this dopaminergic sensitivity to regional brain iron concentration must be determined. We contend, however, that these rodent studies strongly support such a hypothesis.


    FOOTNOTES
 
2 Abbreviations used: CNCN, control; CNID, preweaning control and postweaning iron deficiency; DA, dopamine; DAT, dopamine transporter; D1R, dopamine D1 receptor; D2R, dopamine D2 receptor; ID, iron deficiency; IDCN, preweaning iron deficiency and postweaning control; Hb, hemoglobin; Hct, hematocrit; PFC, prefrontal cortex; PND, postnatal day. Back

Manuscript received 11 September 2002. Initial review completed 16 October 2002. Revision accepted 23 January 2003.


    LITERATURE CITED
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 LITERATURE CITED
 

1. Oski, F. A., Honig, A. S., Helu, B. & Howanitz, P. (1983) Effect of iron therapy on behavioral performance in nonanemic, iron deficient infants. Pediatrics 71:877-880.[Abstract/Free Full Text]

2. Oski, F. A. (1993) Iron deficiency in infancy and childhood. N. Engl. J. Med. 29:190-193.

3. Idjradinata, P. & Pollitt, E. (1993) Reversal of developmental delays in iron-deficient anaemic infants treated with iron. Lancet 341:1-4.[Medline]

4. Lozoff, B., Klein, N. K., Nelson, E. C., McClish, D. K., Manuel, M. & Chacon, M. E. (1998) Behavior of infants with iron deficiency anemia. Child Dev. 69:24-36.[Medline]

5. Lozoff, B. & Brittenham, G. M. (1986) Behavioral aspects of iron deficiency. Prog. Hematol. 14:23-53.[Medline]

6. Pollit, E. (1993) Iron deficiency and cognitive function. Annu. Rev. Nutr. 13:521-538.[Medline]

7. Walter, T. (1993) Impact of iron deficiency on cognition in infancy and childhood. Eur. J. Clin. Nutr. 47:307-316.[Medline]

8. Larkin, E. C. & Rao, G. (1993) Importance of fetal and neonatal iron: adequacy for normal development of central nervous system. Dobbing, J. eds. Brain, Behaviour and Iron in the Infant Diet 1993:43-63 Springer-Verlag London, UK. .

9. Yu, G. S., Steinkirchner, T. M., Rao, G. A. & Larkin, E. C. (1986) Effect of prenatal iron deficiency on myelination in rat pups. Am. J. Pathol. 125:620-624.[Abstract]

10. Roncagliolo, M., Garrido, M., Walter, T., Peirano, P. & Lozoff, B. (1998) Evidence of altered central nervous system development in infants with iron deficiency anemia at 6 mo: delayed maturation of auditory brainstem responses. Am. J. Clin. Nutr. 68:683-690.[Abstract]

11. Ashkenazi, R., Ben-Shachar, A. & Youdim, M.B.H. (1982) Nutritional iron and dopamine binding sites in the rat brain. Pharmacol. Biochem. Behav. 17:43-47.

12. Youdim, M.B.H., Ben-Shachar, D. & Yehuda, S. (1989) Putative biological mechanisms of the effect of iron deficiency on brain biochemistry and behavior. Am. J. Clin. Nutr. 50:607-617.

13. Nelson, C., Erikson, K., Pinero, D. J. & Beard, J. (1997) In vivo dopamine metabolism is altered in iron deficient anemic rats. J. Nutr. 127:2282-2288.[Abstract/Free Full Text]

14. Youdim, M.B.H., Ben-Shachar, D., Ashkenazi, R. & Yehuda, S. (1983) Brain iron and dopamine receptor function. Mandel, P. DeFeudis, F. V. eds. CNS Receptors from Molecular Pharmacology to Behaviour 1983:309-322 Raven Press New York, NY. .

15. Youdim, M.B.H., Yehuda, S. & Ben-Uriah, Y. (1981) Iron deficiency induced circadian rhythm reversal of dopaminergic mediated behaviours and thermoregulation in rats. Eur. J Pharmacol. 74:295-301.[Medline]

16. Hunt, J. R., Zito, C. A., Erjavec, J. & Johnson, L. (1994) Severe or marginal iron deficiency affects spontaneous physical activity in rats. Am. J. Clin. Nutr. 59:413-418.[Abstract/Free Full Text]

17. Pinero, D. J., Li, N. Q., Connor, J. R. & Beard, J. L. (2000) Variations in dietary iron alter brain iron metabolism in developing rats. J. Nutr. 130:254-263.[Abstract/Free Full Text]

18. O’Connor, D. L., Picciano, M. F. & Sherman, A. R. (1988) Impact of maternal iron deficiency on quality and quantity of milk ingested by neonatal rats. Br. J. Nutr. 60:477-485.[Medline]

19. Reeves, P. G., Nielsen, F. H. & Fahey, G. C. (1993) AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr. 123:1939-1951.

20. Methods in Hematology. Cook, J. D. eds. Iron 1 Churchill Livingstone New York, NY .

21. Pinero, D. J, Jones, B. C. & Beard, J. L. (2001) Variations in dietary iron alter behavior in developing rats. J. Nutr. 131:311-318.[Abstract/Free Full Text]

22. Erikson, K., Jones, B. C., Hess, E. J. & Beard, J. L. (2001) Altered function of dopamine D1 and D2 receptors in brains of iron deficient rats. Physiol. Pharmacol. Behav. 69:409-418.

23. Erikson, K., Jones, B. C. & Beard, J. L. (2000) Iron deficiency alters dopamine transporter functioning in rat striatum. J. Nutr. 130:2831-2837.[Abstract/Free Full Text]

24. Erikson, K. M., Pinero, D. J., Connor, J. R. & Beard, J. L. (1997) Regional brain iron, ferritin and transferrin concentrations during iron deficiency and iron repletion in developing rats. J. Nutr. 127:2030-2038.[Abstract/Free Full Text]

25. Hinkle, D. E., Wiersma, W. & Jurs, S. G. (1998) Applied Statistics for the Behavioral Sciences 1998:368-369 Houghton Mifflin New York, NY.

26. Burdo, J. R., Menzies, S. L., Simpson, I. A., Garrick, L. M., Garrick, M. D., Dolan, K. G., Haile, D. J., Beard, J. L. & Connor, J. R. (2001) Distribution of DMT1 and MTP1 in the brain of normal and Belgrade rats. Neuroscience 66:1198-1207.

27. Han, J., Day, J. R., Thompson, K., Connor, J. R. & Beard, J. L. (2000) Iron deficiency alters H and L ferritin in rat brain. Cell. Mol. Biol. 46:517-528.

28. Chen, Q., Connor, J. R. & Beard, J. L. (1995) Brain iron, transferrin and ferritin concentrations are altered in developing iron-deficient rats. J. Nutr. 125:1529-1535.

29. Murrin, L. C. & Zeng, W. Y. (1990) Ontogeny of dopamine D1 receptors in rat forebrain: quantitative autoradiographic study. Dev. Brain Res. 57:7-13.[Medline]

30. Leslie, C. A., Robertson, W. M., Cutler, A. J. & Bennet, J. (1991) Postnatal development of D1 dopamine receptors in medial prefrontal cortex, striatum, and accumbens of normal and neonatal 6-OHDA treated rats: quantitative autoradiographic analysis. Dev. Brain Res. 62:109-114.[Medline]

31. Tarazi, F. I. & Baldessarini, R. J. (2000) Comparative postnatal development of dopamine receptors in rat forebrain. Int. J. Dev. Neurosci. 18:29-37.[Medline]

32. Wiesinger, J., Connor, J. R. & Beard, J. L. (2002) Iron chelation decreases DA transporter density in PC12 and neuroblastoma cells. FASEB J. 16:A340.

33. Iversen, B. & Koob, E. (1977) Behavioral implications of dopaminergic neurons in the mesolimbic system. Adv. Biochem. Psychopharmacol. 16:209-214.[Medline]

34. Beard, J. L., Erikson, K. & Jones, B. C. (2002) Neurobehavioral analysis of developmental iron deficiency in rats. Behav. Brain Res. 134:517-524.[Medline]

35. Roskams, A. J. & Connor, J. R. (1994) Iron, transferrin and ferritin in the rat brain during development and aging. J. Neurochem. 63:709-716.[Medline]




This article has been cited by other articles:


Home page
NeurologyHome page
R. Savica, B. R. Grossardt, J. M. Carlin, M. Icen, J. H. Bower, J. E. Ahlskog, D. M. Maraganore, D. P. Steensma, and W. A. Rocca
Anemia or low hemoglobin levels preceding Parkinson disease: A case-control study
Neurology, October 27, 2009; 73(17): 1381 - 1387.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
J. R. Connor, X.-S. Wang, R. P. Allen, J. L. Beard, J. A. Wiesinger, B. T. Felt, and C. J. Earley
Altered dopaminergic profile in the putamen and substantia nigra in restless leg syndrome
Brain, September 1, 2009; 132(9): 2403 - 2412.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
I. Cetin, C. Berti, and S. Calabrese
Role of micronutrients in the periconceptional period
Hum. Reprod. Update, June 30, 2009; (2009) dmp025v1.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
K. J. Collard
Iron Homeostasis in the Neonate
Pediatrics, April 1, 2009; 123(4): 1208 - 1216.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
E. L. Unger, J. A. Wiesinger, L. Hao, and J. L. Beard
Dopamine D2 Receptor Expression Is Altered by Changes in Cellular Iron Levels in PC12 Cells and Rat Brain Tissue
J. Nutr., December 1, 2008; 138(12): 2487 - 2494.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
P. V. Tran, E. S. Carlson, S. J. B. Fretham, and M. K. Georgieff
Early-Life Iron Deficiency Anemia Alters Neurotrophic Factor Expression and Hippocampal Neuron Differentiation in Male Rats
J. Nutr., December 1, 2008; 138(12): 2495 - 2501.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. L. Beard
Why Iron Deficiency Is Important in Infant Development
J. Nutr., December 1, 2008; 138(12): 2534 - 2536.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. W. Pyatskowit and J. R. Prohaska
Iron Injection Restores Brain Iron and Hemoglobin Deficits in Perinatal Copper-Deficient Rats
J. Nutr., October 1, 2008; 138(10): 1880 - 1886.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
S. L. Bourque, U. Iqbal, J. N. Reynolds, M. A. Adams, and K. Nakatsu
Perinatal Iron Deficiency Affects Locomotor Behavior and Water Maze Performance in Adult Male and Female Rats
J. Nutr., May 1, 2008; 138(5): 931 - 937.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. L. Beard, E. L. Unger, L. E. Bianco, T. Paul, S. E. Rundle, and B. C. Jones
Early Postnatal Iron Repletion Overcomes Lasting Effects of Gestational Iron Deficiency in Rats
J. Nutr., May 1, 2007; 137(5): 1176 - 1182.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
J. C McCann and B. N Ames
An overview of evidence for a causal relation between iron deficiency during development and deficits in cognitive or behavioral function
Am. J. Clinical Nutrition, April 1, 2007; 85(4): 931 - 945.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
M. S. Golub, C. E. Hogrefe, and S. L. Germann
Iron Deprivation during Fetal Development Changes the Behavior of Juvenile Rhesus Monkeys
J. Nutr., April 1, 2007; 137(4): 979 - 984.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. Beard
Recent Evidence from Human and Animal Studies Regarding Iron Status and Infant Development
J. Nutr., February 1, 2007; 137(2): 524S - 530S.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
E. L. Unger, T. Paul, L. E. Murray-Kolb, B. Felt, B. C. Jones, and J. L. Beard
Early Iron Deficiency Alters Sensorimotor Development and Brain Monoamines in Rats
J. Nutr., January 1, 2007; 137(1): 118 - 124.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. G. Penland and J. R. Prohaska
Abnormal Motor Function Persists Following Recovery from Perinatal Copper Deficiency in Rats
J. Nutr., August 1, 2004; 134(8): 1984 - 1988.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
K. Kordas and R. J. Stoltzfus
New Evidence of Iron and Zinc Interplay at the Enterocyte and Neural Tissues
J. Nutr., June 1, 2004; 134(6): 1295 - 1298.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
R. Rao, I. Tkac, E. L. Townsend, R. Gruetter, and M. K. Georgieff
Perinatal Iron Deficiency Alters the Neurochemical Profile of the Developing Rat Hippocampus
J. Nutr., October 1, 2003; 133(10): 3215 - 3221.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beard, J.
Right arrow Articles by Jones, B. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beard, J.
Right arrow Articles by Jones, B. C.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2003 by American Society for Nutrition